v3.26.1
Net Loss Per Share (Tables)
3 Months Ended
Mar. 31, 2026
Earnings Per Share [Abstract]  
Schedule of Calculation of Basic and Diluted Earnings per Share for Common Stock and Preferred Stock

The calculation of basic and diluted earnings per share for our common stock and Preferred Stock is as follows:

 

 

For the Three Months
Ended March 31,

 

 

 

2026

 

 

2025

 

(In thousands, except share and per share data)

 

 

 

Weighted-average common shares outstanding, basic and diluted

 

 

112,424,211

 

 

 

77,126,763

 

Weighted-average shares outstanding of Series X and Series X1 non-voting convertible preferred stock, basic and diluted

 

 

114,508

 

 

 

114,508

 

 

 

 

 

 

 

 

Net loss used in the calculation of basic and diluted loss per share

 

$

(39,025

)

 

$

(6,495

)

 

 

 

 

 

 

 

Net loss available to common stock

 

$

(36,935

)

 

$

(6,000

)

Net loss per share, common stock, basic and diluted

 

$

(0.33

)

 

$

(0.08

)

 

 

 

 

 

 

 

Net loss available to Series X and Series X1 non-voting convertible preferred stock

 

$

(2,090

)

 

$

(495

)

Basic and diluted earnings per share of Series X and Series X1 non-voting convertible preferred stock

 

$

(18.25

)

 

$

(4.32

)

Summary of Potentially Dilutive Securities Outstanding Based on Market Price of Common Stock that were Excluded from the Computation of Diluted Net Loss Per Share

The following table presents potentially dilutive securities outstanding based on the market price of the Company’s common stock as of March 31, 2026 and 2025 that were excluded from the computation of diluted net loss per share because their inclusion would have been anti-dilutive. These securities consist of incentive stock options, restricted stock units and common warrants outstanding during the respective periods.

 

 

 

For the Three Months
Ended March 31,

 

 

 

2026

 

 

2025

 

 

 

 

 

Stock options outstanding and other equity awards

 

 

10,952,838

 

 

 

3,780,189

 

Common and preferred warrants outstanding

 

 

 

 

 

3,117,540

 

Total

 

 

10,952,838

 

 

 

6,897,729